Antipsychotic Effective for Steroid-Induced Psychosis in MS
A popular antipsychotic calms patients with multiple sclerosis (MS) who develop psychiatric distress after taking corticosteroids, a new case review suggests.
Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A popular antipsychotic calms patients with multiple sclerosis (MS) who develop psychiatric distress after taking corticosteroids, a new case review suggests.
Eculizumab is associated with a lower relapse risk and low infection rates in patients with neuromyelitis optical spectrum previously treated with rituximab.
Ponesimod provides clinical benefit over teriflunomide for fatigue among patients with relapsing multiple sclerosis regardless of disease activity status.
Moderate-intensity interventions can help reduce perceived physical and cognitive fatigue in patients with relapsing-remitting multiple sclerosis.
. The authors are Helen M. Genova, PhD, of Kessler Foundation's Center for Neuropsychology and Neuroscience Research, and Stefano Ziccardi, PhD, Marco Pitteri, PhD, and Massimiliano Calabrese, MD, of the University of Verona. Dr. Genova also has an academic appointment at Rutgers University. Some recent MS research, including work led by Dr. Genova, has shown that social cognition deficits may affect people with MS who otherwise have no other cognitive impairments. Social cognition, which is required to understand and process the emotions of others, is an extremely important skill set for for...